GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » FOXO Technologies Inc (AMEX:FOXO) » Definitions » 5-Year Yield-on-Cost %

FOXO (FOXO Technologies) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 15, 2025)


View and export this data going back to 2022. Start your Free Trial

What is FOXO Technologies 5-Year Yield-on-Cost %?

FOXO Technologies's yield on cost for the quarter that ended in Sep. 2024 was 0.00.


The historical rank and industry rank for FOXO Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:



FOXO's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.78
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of FOXO Technologies's 5-Year Yield-on-Cost %

For the Health Information Services subindustry, FOXO Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FOXO Technologies's 5-Year Yield-on-Cost % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where FOXO Technologies's 5-Year Yield-on-Cost % falls into.


;
;

FOXO Technologies 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of FOXO Technologies is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

FOXO Technologies  (AMEX:FOXO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


FOXO Technologies 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of FOXO Technologies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


FOXO Technologies Business Description

Traded in Other Exchanges
N/A
Address
729 Washington Avenue N, Suite 600, Minneapolis, MN, USA, 55401
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
Executives
Martin Christopher Ward officer: Interim CFO CHALKSTREAM, KINGS SOMBORNE, STOCKBRIDGE X0 S020 6NZ
Mark Brian White director, officer: Interim CEO IMMEUBLE MILA, CHAMPERY V8 1874
Dowling Vincent J. Jr 10 percent owner 54 LEDYARD, WEST HARTFORD CT 06117
Gwg Holdings, Inc. 10 percent owner 325 N. ST. PAUL STREET, SUITE 2650, DALLAS TX 75201
Taylor Fay officer: Chief Operating Officer 729 N. WASHINGTON AVE, SUITE 600, MINNEAPOLIS MN 55401
Jon Sabes director, 10 percent owner, officer: CEO, Chairman 701 NORTH THIRD STREET, MINNEAPOLIS MN 55401
Bret Barnes director 220 SOUTH SIXTH STREET, MINNEAPOLIS MN 55402
Brian Chen officer: Chief Science Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Erin Sharoni officer: Chief Product Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Michael Will officer: General Counsel 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Tyler Danielson officer: Chief Technology Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Murdoc Khaleghi director 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Robert Potashnick officer: Chief Financial Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Plc Barclays 10 percent owner 1 CHURCHILL PLACE, CANARY WHARF, LONDON X0 E14 5HP
Paul Britton Newhouse director ONE CITY CENTRE, 1021 MAIN STREET SUITE 1960, HOUSTON TX 77002